Phase 2 trial of NOV-002 [glutathione/cisplatin] with carboplatin in women with recurrent and platinum- resistant tumors of Mullerian origin,
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2015
At a glance
- Drugs Glutathione/cisplatin (Primary) ; Carboplatin
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors Cellectar Biosciences
- 11 Feb 2014 Novelos Therapeutics now known as Cellectar Biosciences
- 08 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2008 Interim results presented at the 2008 annual meeting of the American Society of Clinical Oncology (ASCO).